Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

about

Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide.γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion.

P2860

Q49372092-88FBC7CF-298D-4596-B7CA-160ABBF057CB Q55413334-4F116DAC-E480-413C-AD60-218FA5398C5C

P2860

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Item

http://www.wikidata.org/entity/Q41016131

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Investigating in vitro and in ...... atory γδ T cell immunotherapy.

@en

type

Item

label

Investigating in vitro and in ...... atory γδ T cell immunotherapy.

@en

prefLabel

Investigating in vitro and in ...... atory γδ T cell immunotherapy.

@en

P1476

Investigating in vitro and in ...... natory γδ T cell immunotherapy

@en

P2093

Jane K Sosabowski

http://www.w3.org/2001/XMLSchema#string

John F Marshall

http://www.w3.org/2001/XMLSchema#string

Khuloud T Al-Jamal

http://www.w3.org/2001/XMLSchema#string

Naomi O Hodgins

http://www.w3.org/2001/XMLSchema#string

Pedro M Costa

http://www.w3.org/2001/XMLSchema#string

Rebecca Klippstein

http://www.w3.org/2001/XMLSchema#string

Wafa' T Al-Jamal

http://www.w3.org/2001/XMLSchema#string

P2860

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density

Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

Growth of breast cancer recurrences assessed by consecutive MRI

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker

Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression.

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain.

Effect of ligand density, receptor density, and nanoparticle size on cell targeting

P304

141-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2017.04.025

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

256

http://www.w3.org/2001/XMLSchema#string

P50

John Maher

Julie T-W Wang

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28432037

http://www.w3.org/2001/XMLSchema#string

P932

5488751

http://www.w3.org/2001/XMLSchema#string

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

about

P2860

P2860

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932